Get greater versatility with new respiratory assays on the BD MAX™ System
In a climate of seasonal or pandemic infections, your laboratory should be prepared to face the soaring demands for testing of respiratory tract infections (RTIs).
Due to the highly transmittable nature of RTIs and some overlap of common symptoms, it is critical for your laboratory to reliably detect and differentiate between influenza, SARS-CoV-2, Respiratory Syncytial Virus (RSV), Bordetella pertussis, and Pneumocystis jirovecii.
How are you improving your workflow efficiency to maintain timely and accurate differentiation between the plethora of respiratory pathogens?
Targeted, real-time PCR assays
The BD MAX™ System can simultaneously detect and differentiate respiratory pathogens to facilitate a comprehensive response to COVID-19 and RTIs.
This molecular diagnostic platform is fully automated and capable of analysing hundreds of samples over a 24-hour period with less than 1.5 minutes of hands-on time per sample2,3.
The BD MAX™ System can provide your laboratory with:
- High sensitivity and specificity for targeted detection
- Timely results for patient management
- Flexibility of diagnostic testing with a broad menu of respiratory assays compatible with other BD MAX™ assays
Optimise your workflow with rapid and sensitive results obtained across a broad menu of respiratory assays to ensure infection management processes can curb the ever-growing spread of pathogens this season.
Consolidate your molecular testing to the BD MAX™ System and discover new respiratory assays
BD Respiratory Viral Panel for BD MAX™ System (SARS-CoV-2, Flu A, Flu B, RSV)
Give 4 results from 1 specimen in a single run
VIASURE Pneumocystis jirovecii Real Time PCR Detection Kit for BD MAX™ System
Test for the cause of Pneumocystis pneumonia with the BD MAX™ System
VIASURE Bordetella Real Time PCR Detection Kit for BD MAX™ System*
Detect and differentiate between three Bordetella species
The innovation of the BD MAX™ System offers you a fully integrated, automated real-time PCR benchtop platform with the possibility of running simultaneously its broad menu of molecular in vitro diagnostics (IVDs) and open-system tests.**
- Less than 1.5 minutes hands-on time per sample2,3
- 24 patient results in an average of 2.5 hours3
- 96 samples per 8-hour shift3
Its automated workflow reduces manual tasks to achieve rapid, reliable results and facilitates off-hour testing, helping to offset molecular testing costs.***1,2
